Live feed
Filing
SC 13G
SC 13G0001193125-20-166752·VYNE Therapeutics Inc.
Schedule 13G ownership disclosure
Menlo Therapeutics, Inc.
Security class unavailable · CUSIP: 586858102
Event date: 2020-03-09
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 14.0000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001193125-20-166752
- Form type
- SC 13G
- Filer
- VYNE Therapeutics Inc.
- CIK
- CIK 1566044
- Filed
- Jun 11, 2020
- Reporting period
- Mar 09, 2020
- Description
- Schedule 13G beneficial ownership